PortfoliosLab logoPortfoliosLab logo
BBLGW vs. CALM
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BBLGW vs. CALM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bone Biologics Corp Warrants (BBLGW) and Cal-Maine Foods, Inc. (CALM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBLGW achieves a 13.74% return, which is significantly higher than CALM's -4.04% return.


BBLGW

1D
0.74%
1M
-11.81%
YTD
13.74%
6M
-18.76%
1Y
30.59%
3Y*
179.55%
5Y*
10Y*

CALM

1D
1.10%
1M
0.80%
YTD
-4.04%
6M
-7.64%
1Y
-18.41%
3Y*
22.93%
5Y*
22.21%
10Y*
8.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBLGW vs. CALM - Yearly Performance Comparison


2026 (YTD)20252024202320222021
BBLGW
Bone Biologics Corp Warrants
13.74%-61.25%920.41%638.23%-97.47%-41.18%
CALM
Cal-Maine Foods, Inc.
-4.04%-15.61%87.00%14.48%51.87%7.09%

Correlation

The correlation between BBLGW and CALM is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.02

Correlation (3Y)
Calculated over the trailing 3-year period

-0.01

Correlation (All Time)
Calculated using the full available price history since Oct 14, 2021

0.03

Fundamentals

Market Cap

BBLGW:

$31.65M

CALM:

$3.57B

EPS

BBLGW:

-$2.15

CALM:

$14.48

PB Ratio

BBLGW:

6.78

CALM:

1.32

Total Revenue (TTM)

BBLGW:

$0.00

CALM:

$3.46B

Gross Profit (TTM)

BBLGW:

$0.00

CALM:

$1.17B

EBITDA (TTM)

BBLGW:

-$2.90M

CALM:

$1.05B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBLGW vs. CALM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBLGW
BBLGW Risk / Return Rank: 6060
Overall Rank
BBLGW Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
BBLGW Sortino Ratio Rank: 6262
Sortino Ratio Rank
BBLGW Omega Ratio Rank: 8787
Omega Ratio Rank
BBLGW Calmar Ratio Rank: 5252
Calmar Ratio Rank
BBLGW Martin Ratio Rank: 5252
Martin Ratio Rank

CALM
CALM Risk / Return Rank: 2020
Overall Rank
CALM Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CALM Sortino Ratio Rank: 1717
Sortino Ratio Rank
CALM Omega Ratio Rank: 1717
Omega Ratio Rank
CALM Calmar Ratio Rank: 2323
Calmar Ratio Rank
CALM Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBLGW vs. CALM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bone Biologics Corp Warrants (BBLGW) and Cal-Maine Foods, Inc. (CALM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BBLGWCALMDifference

Sharpe ratio

Return per unit of total volatility

0.25

-0.56

+0.80

Sortino ratio

Return per unit of downside risk

1.32

-0.64

+1.96

Omega ratio

Gain probability vs. loss probability

1.38

0.92

+0.46

Calmar ratio

Return relative to maximum drawdown

0.48

-0.50

+0.98

Martin ratio

Return relative to average drawdown

1.06

-0.79

+1.85

BBLGW vs. CALM - Sharpe Ratio Comparison

The current BBLGW Sharpe Ratio is 0.25, which is higher than the CALM Sharpe Ratio of -0.56. The chart below compares the historical Sharpe Ratios of BBLGW and CALM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BBLGWCALMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.25

-0.56

+0.80

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.69

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.06

0.38

-0.44

Drawdowns

BBLGW vs. CALM - Drawdown Comparison

The maximum BBLGW drawdown since its inception was -98.80%, which is greater than CALM's maximum drawdown of -74.08%. Use the drawdown chart below to compare losses from any high point for BBLGW and CALM.


Loading charts...

Drawdown Indicators


BBLGWCALMDifference

Max Drawdown

Largest peak-to-trough decline

-98.80%

-74.08%

-24.72%

Max Drawdown (1Y)

Largest decline over 1 year

-63.81%

-37.00%

-26.81%

Max Drawdown (3Y)

Largest decline over 3 years

-96.92%

-37.00%

-59.92%

Max Drawdown (5Y)

Largest decline over 5 years

-37.00%

Max Drawdown (10Y)

Largest decline over 10 years

-39.12%

Current Drawdown

Current decline from peak

-81.44%

-33.59%

-47.85%

Average Drawdown

Average peak-to-trough decline

-70.86%

-30.31%

-40.55%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.88%

23.36%

+5.52%

Volatility

BBLGW vs. CALM - Volatility Comparison

Bone Biologics Corp Warrants (BBLGW) has a higher volatility of 44.61% compared to Cal-Maine Foods, Inc. (CALM) at 7.35%. This indicates that BBLGW's price experiences larger fluctuations and is considered to be riskier than CALM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBLGWCALMDifference

Volatility (1M)

Calculated over the trailing 1-month period

44.61%

7.35%

+37.26%

Volatility (6M)

Calculated over the trailing 6-month period

111.61%

20.50%

+91.11%

Volatility (1Y)

Calculated over the trailing 1-year period

124.83%

33.15%

+91.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

251.46%

32.60%

+218.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

251.46%

31.16%

+220.30%

Dividends

BBLGW vs. CALM - Dividend Comparison

BBLGW has not paid dividends to shareholders, while CALM's dividend yield for the trailing twelve months is around 6.37%.


PositionTTM20252024202320222021202020192018201720162015
BBLGW
Bone Biologics Corp Warrants
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CALM
Cal-Maine Foods, Inc.
6.37%10.90%2.82%7.51%3.17%0.09%0.00%0.98%1.03%0.00%2.70%4.10%

Financials

BBLGW vs. CALM - Financials Comparison

This section allows you to compare key financial metrics between Bone Biologics Corp Warrants and Cal-Maine Foods, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B202220232024202520260
666.95M
(BBLGW) Total Revenue
(CALM) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BBLGW and CALM have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBLGW has higher volatility (44.61%) compared to CALM (7.35%). In terms of maximum drawdown, BBLGW dropped -98.80% vs CALM's -74.08%.

BBLGW currently has the higher Sharpe Ratio (0.25 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBLGW and CALM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer